Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

Chinese startup DeepSeek has debuted an AI app that challenges OpenAI's ChatGPT and other U.S. rivals, sending a shock ...

Wedbush analyst Nick Setyan raised the firm’s price target on Dutch Bros (BROS) to $80 from $65 and keeps an Outperform rating on the shares.

Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...

Wedbush also issued estimates for General Motors’ Q2 2025 earnings at $3.02 EPS, Q3 2025 earnings at $3.22 EPS, Q4 2025 earnings at $2.67 EPS, FY2025 earnings at $11.60 EPS, Q2 2026 earnings at ...

Welltower Inc. (NYSE:WELL – Free Report) – Research analysts at Wedbush issued their Q1 2025 earnings estimates for Welltower in a report released on Wednesday, January 29th. Wedbush analyst R.

Dan Ives, Wedbush Securities, joins 'Closing Bell Overtime' to talk Tesla and Microsoft earnings. White House says Trump ...

Wedbush's Dan Ives believes buying Palantir Technologies Inc (NYSE:PLTR) stock right now could be like buying Tesla Inc ...

Palantir Technologies is set to report fourth-quarter results after the market closes Monday, with analysts expecting revenue and adjusted earnings growth.